financetom
Business
financetom
/
Business
/
Arbitration between miner Franco-Nevada, Panama moves to next stage
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Arbitration between miner Franco-Nevada, Panama moves to next stage
Dec 11, 2024 12:37 PM

Dec 11 (Reuters) - Arbitration proceedings between

Canadian miner Franco-Nevada ( FNV ) and Panama over the Cobre Panama

copper mine entered a new phase this week with the formation of

a tribunal to hear the case, according to legal disclosures

filed by the parties.

Investors are awaiting Panama President Jose Raul Mulino's

decision over the future of the mine, which was shut down last

year due to public unrest. Cobre Panama is the flagship mine of

Canadian miner First Quantum Minerals ( FQVLF ), which is also

seeking damages from Panama.

Franco-Nevada ( FNV ) had a streaming agreement with First

Quantum to buy gold and copper from Cobre Panama in return for

financing mine operations.

Franco-Nevada ( FNV ) is seeking $5 billion in damages from Panama under

the Canada-Panama free-trade agreement.

In 2023, Franco-Nevada ( FNV ) took a $1-billion charge due to the

mine's closure. First Quantum has sought damages of at least $20

billion and Orla Mining ( ORLA ), which had its separate mining

contract canceled last year, is claiming at least $400 million

from Panama. The next stage is formal arbitration proceedings in

which the parties present their arguments.

Cobre Panama has become a flashpoint in the mining industry as

its closure has removed 1% of global copper supply. Mulino has

said his government will decide the mine's fate early next year,

even as the arbitration cases proceed.

Rating agency Moody's cut Panama's outlook to negative in

November and pointed out potential credit risks due to the

ongoing litigation.

"Absent measures to address this risk, including reopening

negotiations with the mine's operators, the government's credit

profile could face a severe financial shock in case of an

adverse ruling," Moody's said.

Franco-Nevada ( FNV ) did not respond to a request for comment.

First Quantum declined to comment.

Shares of Franco-Nevada ( FNV ) were down 1.7% in Toronto and First

Quantum dipped 0.5%.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tesla Recalls 2,431 Cybertrucks Over Faulty Inverters
Tesla Recalls 2,431 Cybertrucks Over Faulty Inverters
Nov 13, 2024
07:13 AM EST, 11/13/2024 (MT Newswires) -- Tesla (TSLA) is recalling 2,431 Cybertruck electric pickups due to a fault in the drive inverter that may cause potential loss of drive power to the wheels, increasing the risk of accidents, according to the National Highway Traffic Safety Administration Tuesday. Included in the recall are Cybertruck vehicles manufactured between Nov. 6, 2023,...
BRIEF-Spire Global Announces Strategic Business Update; Debt To Be Eliminated
BRIEF-Spire Global Announces Strategic Business Update; Debt To Be Eliminated
Nov 13, 2024
Nov 13 (Reuters) - Spire Global Inc ( SPIR ): * SPIRE GLOBAL ANNOUNCES STRATEGIC BUSINESS UPDATE; DEBT TO BE ELIMINATED * SPIRE GLOBAL INC ( SPIR ) - INTENDS TO ELIMINATE DEBT THROUGH SALE PROCEEDS * SPIRE GLOBAL INC ( SPIR ): TO SELL ITS MARITIME BUSINESS TO KPLER FOR ABOUT $241 MILLION * SPIRE GLOBAL INC ( SPIR...
BRIEF-Coterra Announces Accretive Permian Basin Acquisitions
BRIEF-Coterra Announces Accretive Permian Basin Acquisitions
Nov 13, 2024
Nov 13 (Reuters) - Coterra Energy Inc ( CTRA ): * COTERRA ANNOUNCES ACCRETIVE PERMIAN BASIN ACQUISITIONS * COTERRA ENERGY INC ( CTRA ): PROPOSED DEAL FOR AGGREGATE CONSIDERATION OF $3.95 BILLION * COTERRA ENERGY INC ( CTRA ): CONSIDERATION CONSISTING OF $2.95 BILLION OF CASH AND $1.0 BILLION OF COTERRA COMMON STOCK * COTERRA: CASH PORTION OF DEAL EXPECTED...
Gilead Sciences Says Investigational HIV Prevention Drug Showed High Infection Reduction
Gilead Sciences Says Investigational HIV Prevention Drug Showed High Infection Reduction
Nov 13, 2024
08:26 AM EST, 11/13/2024 (MT Newswires) -- Gilead Sciences ( GILD ) said Wednesday the full results of its phase 3 study on lenacapavir, an investigational HIV prevention injection, showed high rates of infection reductions. The company said that 99.9% of lenacapavir participants did not acquire HIV, with only two cases among 2,179 participants that reported high levels of sexual...
Copyright 2023-2026 - www.financetom.com All Rights Reserved